Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY®
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
Pfizer and BioNTech request regulatory agencies expand emergency use of their COVID-19 vaccine to adolescents
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
Valneva reports positive Phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001
- Details
- Category: Business
![Valneva Valneva](/images/logo/valneva.png)
Pfizer and BioNTech confirm high efficacy and no serious safety concerns through up to six months following second dose in updated topline analysis of landmark COVID-19 vaccine study
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
BioNTech provides update on vaccine production status at Marburg manufacturing site
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
NIAID statement on AstraZeneca vaccine and AstraZeneca update
- Details
- Category: Business
Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial. The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.
Bharat Biotech announces Phase 3 results of COVAXIN®: India's first COVID-19 vaccine demonstrates interim clinical efficacy of 81%
- Details
- Category: Business
![Bharat Biotech Bharat Biotech](/images/logo/bharatbiotech.png)
More Pharma News ...
- WHO statement on AstraZeneca COVID-19 vaccine safety signals
- First participants dosed in Phase 1 study evaluating mRNA-1283, Moderna's next generation COVID-19 vaccine
- European Commission purchases additional 150 million doses of COVID-19 vaccine Moderna
- U.S. government purchases additional 100 million doses of Moderna's COVID-19 vaccine
- CureVac initiates rolling submission with European Medicines Agency for COVID-19 vaccine candidate, CVnCoV
- Sinovac receives conditional marketing authorization in China for its COVID-19 vaccine
- Pfizer and BioNTech publish data from in vitro studies demonstrating COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants